Cargando…

Serum Selenium Levels in Patients with Graves Disease: Associations with Clinical Activity and Severity in a Retrospective Case-control Study

PURPOSE: To compare serum selenium levels in Graves patients and non-Graves control participants and to evaluate associations between serum selenium levels and clinical features of Graves orbitopathy (GO). METHODS: We conducted a single-center, retrospective case-control study among 33 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae Hwan, Ko, JaeSang, Kim, Bo Ram, Shin, Dong Yeob, Lee, Eun Jig, Yoon, Jin Sook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Ophthalmological Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849989/ https://www.ncbi.nlm.nih.gov/pubmed/34743487 http://dx.doi.org/10.3341/kjo.2021.0146

Ejemplares similares

Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves’ Orbitopathy in Orbital Fibroblasts
por: Lee, Ga Eun, et al.
Publicado: (2021)

Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves’ orbital fibroblasts
por: Lee, Sung Jun, et al.
Publicado: (2018)

Protein tyrosine phosphatase 1B as a therapeutic target for Graves’ orbitopathy in an in vitro model
por: Byeon, Hyeong Ju, et al.
Publicado: (2020)

The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves’ Orbitopathy
por: Byeon, Hyeong Ju, et al.
Publicado: (2023)

Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves’ Orbitopathy
por: Kim, Bo Yi, et al.
Publicado: (2022)

Correlation between TSH Receptor Antibody Assays and Clinical Manifestations of Graves' Orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2013)

Therapeutic Effect of Guggulsterone in Primary Cultured Orbital Fibroblasts Obtained From Patients with Graves’ Orbitopathy
por: Kim, Bo Ram, et al.
Publicado: (2020)

Comparative assessment of Graves’ disease and main extrathyroidal manifestation, Graves’ ophthalmopathy, by non-targeted metabolite profiling of blood and orbital tissue
por: Ji, Dong Yoon, et al.
Publicado: (2018)

Therapeutic effect of ibrutinib, a selective Bruton’s tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves’ orbitopathy
por: Park, Hyun Young, et al.
Publicado: (2022)

Thyroid Isthmus Length and Iodine Turnover as Predictors of Successful Radioactive Iodine Therapy in Patients with Graves' Disease
por: Park, Se Hee, et al.
Publicado: (2017)

Therapeutic Potential of Targeting Periostin in the Treatment of Graves’ Orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2022)

Leptomeningeal Seeding in Choroidal Melanoma after Enucleation Surgery
por: Kim, Tae Hwan, et al.
Publicado: (2020)

Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves’ orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2021)

Low Serum Vitamin D Is Associated with Anti-Thyroid Peroxidase Antibody in Autoimmune Thyroiditis
por: Shin, Dong Yeob, et al.
Publicado: (2014)

A Pilot Clinical Study of Ocular Prosthesis Fabricated by Three-dimensional Printing and Sublimation Technique
por: Kim, Bo Ram, et al.
Publicado: (2021)

Inhibitory Effects of α-Lipoic Acid on Oxidative Stress-Induced Adipogenesis in Orbital Fibroblasts From Patients With Graves Ophthalmopathy
por: Hwang, Sena, et al.
Publicado: (2016)

Quercetin Inhibits IL-1β-Induced Inflammation, Hyaluronan Production and Adipogenesis in Orbital Fibroblasts from Graves' Orbitopathy
por: Yoon, Jin Sook, et al.
Publicado: (2011)

MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves’ orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2019)

Sarcopenia as a potential risk factor for senile blepharoptosis: Nationwide Surveys (KNHANES 2008–2011)
por: Byeon, Hyeong Ju, et al.
Publicado: (2023)

Kimura Disease with Lacrimal Sac and Nasolacrimal Duct Involvement: A Case Report
por: Byeon, Hyeong Ju, et al.
Publicado: (2023)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)

Glycogen Synthase Kinase-3β Mediates Proinflammatory Cytokine Secretion and Adipogenesis in Orbital Fibroblasts from Patients with Graves’ Orbitopathy
por: Lee, Jihei Sara, et al.
Publicado: (2020)

FRI533 A Novel Cre-loxP Based Mouse Model For Graves' Disease
por: Kim, Daham, et al.
Publicado: (2023)

The Evolving Role of Selenium in the Treatment of Graves' Disease and Ophthalmopathy
por: Duntas, Leonidas H.
Publicado: (2012)

Challenges and perspectives of selenium supplementation in Graves’ disease and orbitopathy
por: Bednarczuk, Tomasz, et al.
Publicado: (2019)

Semi-automated fabrication of customized ocular prosthesis with three–dimensional printing and sublimation transfer printing technology
por: Ko, JaeSang, et al.
Publicado: (2019)

Treatment of Exposed Hydroxyapatite Orbital Implants Wrapped with a Synthetic Dura Substitute
por: Shin, Woo Beom, et al.
Publicado: (2019)

Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis: A case report and literature review
por: Ko, JaeSang, et al.
Publicado: (2017)

Congenital Orbital Fibrosis: Molecular Genetic Analysis by Whole-Exome and Mitochondrial Genome Sequencing
por: Ko, JaeSang, et al.
Publicado: (2017)

Orbital Venous Malformation Accompanied by Arteriovenous Fistula
por: Byeon, Hyeong Ju, et al.
Publicado: (2020)

Longitudinal association of thyroid-stimulating immunoglobulin levels with clinical characteristics in thyroid eye disease
por: Ko, JaeSang, et al.
Publicado: (2022)

Serum selenium status in Graves’ disease and Hashimoto's thyroiditis in an iodine-sufficient area: A case–control study
por: Heidari, Zahra, et al.
Publicado: (2022)

Clinical Correlation between Gastric Cancer Type and Serum Selenium and Zinc Levels
por: Ji, Jae Hyo, et al.
Publicado: (2012)

Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves’ Disease: A Retrospective Multicenter Study
por: Yoon, Jee Hee, et al.
Publicado: (2021)

Relative selenium insufficiency is a risk factor for developing severe Graves’ orbitopathy: a case–control study
por: Lumyongsatien, Mingkwan, et al.
Publicado: (2021)

Myopathy Associated with Treatment of Graves’ Disease
por: Ji, Yoon-Kyung, et al.
Publicado: (2021)

Graves’ Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study
por: Cho, Yoon Young, et al.
Publicado: (2022)

Serum Concentrations of Trace Elements Zinc, Copper, Selenium, and Manganese in Critically Ill Patients
por: Lee, Yeon Hee, et al.
Publicado: (2018)

Effects of Selenium Supplementation on Graves' Disease: A Systematic Review and Meta-Analysis
por: Zheng, Huijuan, et al.
Publicado: (2018)

Sex-specific genetic influence on thyroid-stimulating hormone and free thyroxine levels, and interactions between measurements: KNHANES 2013–2015
por: Lee, Young Ki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bb62m2tgt2ms2el42nfne65bce